New strategies to prevent and treat endometrial cancer
Route 66 Endometrial Cancer SPORE
This study is looking for new ways to prevent and treat endometrial cancer, especially for women with advanced or recurring cases, and it offers opportunities for patients to join clinical trials testing these exciting new options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10912608 on NIH RePORTER |
What this research studies
The Route 66 Endometrial Cancer SPORE is a collaborative program involving three institutions focused on developing innovative approaches to prevent and treat endometrial cancer. It includes multiple research projects that aim to test new therapies and improve treatment responses, particularly for patients with advanced or recurrent endometrial cancer. The program also emphasizes early detection and prevention strategies for women at risk, especially those with obesity and endometrial hyperplasia. Patients may participate in clinical trials that explore these new treatment options and preventive measures.
Who could benefit from this research
Good fit: Ideal candidates for participation include women diagnosed with endometrial cancer, particularly those with advanced or recurrent forms, as well as premenopausal women with obesity and endometrial hyperplasia.
Not a fit: Patients with early-stage endometrial cancer who are not eligible for clinical trials or those without the specific conditions being targeted may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and prevention strategies for endometrial cancer, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in similar approaches to cancer treatment and prevention, indicating potential for success in this novel program.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Mutch, David G — Washington University
- Study coordinator: Mutch, David G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.